Szymulewska-Konopko K, Reszec-Gielazyn J, Maleczek M
Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852175
PMC: 11763953.
DOI: 10.3390/cimb47010060.
Tao Z, Shen C
Bone Joint Res. 2024; 13(9):427-440.
PMID: 39216851
PMC: 11365736.
DOI: 10.1302/2046-3758.139.BJR-2023-0396.R3.
Stojsavljevic A, Jagodic J, Perovic T, Manojlovic D, Pavlovic S
Biomedicines. 2024; 12(7).
PMID: 39062163
PMC: 11274787.
DOI: 10.3390/biomedicines12071589.
Salimi Z, Afsharinasab M, Rostami M, Eshaghi Milasi Y, Mousavi Ezmareh S, Sakhaei F
Ann Med Surg (Lond). 2024; 86(5):2759-2776.
PMID: 38694398
PMC: 11060230.
DOI: 10.1097/MS9.0000000000001717.
Smith K, Gwyer Findlay E
Discov Immunol. 2024; 1(1):kyac003.
PMID: 38566904
PMC: 10917193.
DOI: 10.1093/discim/kyac003.
Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas.
Onciul R, Brehar F, Toader C, Covache-Busuioc R, Glavan L, Bratu B
Curr Issues Mol Biol. 2024; 46(3):2402-2443.
PMID: 38534769
PMC: 10969338.
DOI: 10.3390/cimb46030153.
Iron Bioavailability in the Extracellular Environment Is More Relevant Than the Intracellular One in Viability and Gene Expression: A Lesson from Oligodendroglioma Cells.
Braidotti S, Curci D, Zampieri D, Covino C, Zanon D, Maximova N
Biomedicines. 2023; 11(11).
PMID: 38001941
PMC: 10668974.
DOI: 10.3390/biomedicines11112940.
HMGB1 induces hepcidin upregulation in astrocytes and causes an acute iron surge and subsequent ferroptosis in the postischemic brain.
Davaanyam D, Lee H, Seol S, Oh S, Kim S, Lee J
Exp Mol Med. 2023; 55(11):2402-2416.
PMID: 37907744
PMC: 10689467.
DOI: 10.1038/s12276-023-01111-z.
Non-invasive assessment of normal and impaired iron homeostasis in the brain.
Filo S, Shaharabani R, Bar Hanin D, Adam M, Ben-David E, Schoffman H
Nat Commun. 2023; 14(1):5467.
PMID: 37699931
PMC: 10497590.
DOI: 10.1038/s41467-023-40999-z.
Apo- and holo-transferrin differentially interact with hephaestin and ferroportin in a novel mechanism of cellular iron release regulation.
Baringer S, Palsa K, Spiegelman V, Simpson I, Connor J
J Biomed Sci. 2023; 30(1):36.
PMID: 37277838
PMC: 10243088.
DOI: 10.1186/s12929-023-00934-2.
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.
Formica V, Riondino S, Morelli C, Guerriero S, DAmore F, Di Grazia A
Br J Cancer. 2023; 129(2):222-236.
PMID: 37081189
PMC: 10338631.
DOI: 10.1038/s41416-023-02266-2.
Functionalization of curcumin nanomedicines: a recent promising adaptation to maximize pharmacokinetic profile, specific cell internalization and anticancer efficacy against breast cancer.
Zhang J, Sun J, Li C, Qiao H, Hussain Z
J Nanobiotechnology. 2023; 21(1):106.
PMID: 36964547
PMC: 10039588.
DOI: 10.1186/s12951-023-01854-x.
Distinctive modulation of hepcidin in cancer and its therapeutic relevance.
Lin F, Tuffour A, Hao G, Addai Peprah F, Huang A, Zhou Y
Front Oncol. 2023; 13:1141603.
PMID: 36895478
PMC: 9989193.
DOI: 10.3389/fonc.2023.1141603.
On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson's Disease.
Garcia-Beltran O, Urrutia P, Nunez M
Antioxidants (Basel). 2023; 12(2).
PMID: 36829773
PMC: 9952574.
DOI: 10.3390/antiox12020214.
Apo- and holo- transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier.
Baringer S, Palsa K, Simpson I, Connor J
bioRxiv. 2023; .
PMID: 36712094
PMC: 9882075.
DOI: 10.1101/2023.01.10.522344.
Apo- and holo- transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier.
Baringer S, Palsa K, Simpson I, Connor J
Res Sq. 2023; .
PMID: 36711476
PMC: 9882672.
DOI: 10.21203/rs.3.rs-2429356/v1.
Contribution of miR-124 rs531564 polymorphism to the occurrence of congenital Zika syndrome.
Gomes J, Vieira I, Sgarioni E, Tercas-Tretell A, da Silva J, Ribeiro B
Epigenetics. 2022; 18(1):2145061.
PMID: 36411728
PMC: 9980461.
DOI: 10.1080/15592294.2022.2145061.
Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities.
Luo Y, Tian G, Fang X, Bai S, Yuan G, Pan Y
Antioxidants (Basel). 2022; 11(11).
PMID: 36358495
PMC: 9686959.
DOI: 10.3390/antiox11112123.
Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.
Dong T, Zhang B, Zhang R, Wang C, Liu X, Wang F
Front Oncol. 2022; 12:963096.
PMID: 36237302
PMC: 9552819.
DOI: 10.3389/fonc.2022.963096.
A role for ceruloplasmin in the control of human glioblastoma cell responses to radiation.
Roy C, Avril S, Legendre C, Lelievre B, Vellenriter H, Boni S
BMC Cancer. 2022; 22(1):843.
PMID: 35918659
PMC: 9347084.
DOI: 10.1186/s12885-022-09808-6.